Men's

Guidelines (12)

Men's in the News

News in brief - January 2015 (updated)

News in brief - January 2015 (updated)

Other new launches, licence changes and updates relevant...

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi (enzalutamide) is an anti-androgen licensed...

Zytiga approved for use before chemotherapy

Zytiga approved for use before chemotherapy

The licence for Zytiga (abiraterone) has been extended...

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more